GenTrust LLC Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

GenTrust LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 194,555 shares of the exchange traded fund’s stock after selling 8,079 shares during the quarter. SPDR S&P Biotech ETF accounts for 1.1% of GenTrust LLC’s investment portfolio, making the stock its 19th largest holding. GenTrust LLC owned 0.25% of SPDR S&P Biotech ETF worth $18,461,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $396,844,000. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 35.9% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock valued at $214,832,000 after purchasing an additional 635,000 shares in the last quarter. Phoenix Holdings Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 0.8% in the third quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock valued at $157,092,000 after purchasing an additional 17,221 shares during the period. Employees Retirement System of Texas acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $27,456,000. Finally, Blackstone Inc. boosted its holdings in SPDR S&P Biotech ETF by 674.8% during the fourth quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock worth $30,093,000 after buying an additional 293,530 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI traded down $0.49 on Thursday, hitting $90.87. 4,682,011 shares of the company were exchanged, compared to its average volume of 10,621,511. The business’s fifty day moving average is $90.58 and its 200 day moving average is $90.94. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market capitalization of $6.93 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.